Selective antimicrobial activity and mode of action of adepantins, glycine-rich peptide antibiotics based on anuran antimicrobial peptide sequences.

A challenge when designing membrane-active peptide antibiotics with therapeutic potential is how to ensure a useful antibacterial activity whilst avoiding unacceptable cytotoxicity for host cells. Understanding their mode of interaction with membranes and the reasons underlying their ability to distinguish between bacterial and eukaryotic cytoplasmic cells is crucial for any rational attempt to improve this selectivity. We have approached this problem by analysing natural helical antimicrobial peptides of anuran origin, using a structure-activity database to determine an antimicrobial selectivity index (SI) relating the minimal inhibitory concentration against Escherichia coli to the haemolytic activity (SI=HC(50)/MIC). A parameter that correlated strongly with SI, derived from the lengthwise asymmetry of the peptides' hydrophobicity (sequence moment), was then used in the "Designer" algorithm to propose novel, highly selective peptides. Amongst these are the 'adepantins', peptides rich in glycines and lysines that are highly selective for Gram-negative bacteria, have an exceptionally low haemolytic activity, and are less than 50% homologous to any other natural or synthetic antimicrobial peptide. In particular, they showed a very high SI for E. coli (up to 400) whilst maintaining an antimicrobial activity in the 0.5-4μM range. Experiments with monomeric, dimeric and fluorescently labelled versions of the adepantins, using different bacterial strains, host cells and model membrane systems provided insight into their mechanism of action.

[1]  Alessandro Tossi,et al.  Amphipathic, α‐helical antimicrobial peptides , 2000 .

[2]  Olivier Taboureau,et al.  Design of Novispirin Antimicrobial Peptides by Quantitative Structure–Activity Relationship , 2006, Chemical biology & drug design.

[3]  D. Scaini,et al.  Primate cathelicidin orthologues display different structures and membrane interactions. , 2009, The Biochemical journal.

[4]  C. Whitfield,et al.  Involvement of waaY, waaQ, andwaaP in the Modification of Escherichia coliLipopolysaccharide and Their Role in the Formation of a Stable Outer Membrane* , 1998, The Journal of Biological Chemistry.

[5]  W. J. Waddell,et al.  A simple ultraviolet spectrophotometric method for the determination of protein. , 1956, The Journal of laboratory and clinical medicine.

[6]  A. Tossi,et al.  Amphipathic alpha helical antimicrobial peptides. , 2001, European journal of biochemistry.

[7]  R. Jones,et al.  In vitro evaluation of CENTA, a new beta-lactamase-susceptible chromogenic cephalosporin reagent , 1982, Journal of clinical microbiology.

[8]  H. Guy Amino acid side-chain partition energies and distribution of residues in soluble proteins. , 1985, Biophysical journal.

[9]  Jing Zhang,et al.  Disulfide bond formation in peptides by dimethyl sulfoxide. Scope and applications , 1991 .

[10]  Alessandro Tossi,et al.  Controlled alteration of the shape and conformational stability of alpha-helical cell-lytic peptides: effect on mode of action and cell specificity. , 2005, The Biochemical journal.

[11]  H. Vogel,et al.  The expanding scope of antimicrobial peptide structures and their modes of action. , 2011, Trends in biotechnology.

[12]  M. Benincasa,et al.  Role of the Escherichia coli SbmA in the antimicrobial activity of proline‐rich peptides , 2007, Molecular microbiology.

[13]  H. Gruppen,et al.  Prediction of molar extinction coefficients of proteins and peptides using UV absorption of the constituent amino acids at 214 nm to enable quantitative reverse phase high-performance liquid chromatography-mass spectrometry analysis. , 2007, Journal of agricultural and food chemistry.

[14]  R. Gennaro,et al.  Identification and characterization of a primary antibacterial domain in CAP18, a lipopolysaccharide binding protein from rabbit leukocytes , 1994, FEBS letters.

[15]  M. Zasloff Antimicrobial peptides of multicellular organisms , 2002, Nature.

[16]  A. Tossi,et al.  Alpha-helical antimicrobial peptides--using a sequence template to guide structure-activity relationship studies. , 2006, Biochimica et biophysica acta.

[17]  A. Tossi,et al.  Wide-spectrum antibiotic activity of synthetic, amphipathic peptides. , 1998, Biochemical and biophysical research communications.

[18]  Riadh Hammami,et al.  Current trends in antimicrobial agent research: chemo- and bioinformatics approaches. , 2010, Drug discovery today.

[19]  J. Reed,et al.  A set of constructed type spectra for the practical estimation of peptide secondary structure from circular dichroism. , 1997, Analytical biochemistry.

[20]  M. Benincasa,et al.  Antimicrobial activity of Bac7 fragments against drug-resistant clinical isolates , 2004, Peptides.

[21]  Robert E. W. Hancock,et al.  Multifunctional cationic host defence peptides and their clinical applications , 2011, Cellular and Molecular Life Sciences.

[22]  M. Benincasa,et al.  Dual mode of action of Bac7, a proline-rich antibacterial peptide. , 2006, Biochimica et biophysica acta.

[23]  Davor Juretic,et al.  Computational Design of Highly Selective Antimicrobial Peptides , 2009, J. Chem. Inf. Model..

[24]  Michael R. Yeaman,et al.  Unifying themes in host defence effector polypeptides , 2007, Nature Reviews Microbiology.

[25]  Yibing Huang,et al.  Alpha-helical cationic antimicrobial peptides: relationships of structure and function , 2010, Protein & Cell.

[26]  M. Benincasa,et al.  Investigating the mode of action of proline-rich antimicrobial peptides using a genetic approach: a tool to identify new bacterial targets amenable to the design of novel antibiotics. , 2008, Methods in molecular biology.

[27]  Bono Lučić,et al.  Knowledge-based computational methods for identifying or designing novel, non-homologous antimicrobial peptides , 2011, European Biophysics Journal.

[28]  Gary Taubes,et al.  The Bacteria Fight Back , 2008, Science.

[29]  J. Janin,et al.  Surface and inside volumes in globular proteins , 1979, Nature.

[30]  H. Sahl,et al.  The co-evolution of host cationic antimicrobial peptides and microbial resistance , 2006, Nature Reviews Microbiology.

[31]  Michael Bienert,et al.  Optimization of the antimicrobial activity of magainin peptides by modification of charge , 2001, FEBS letters.